COMMUNIQUÉS West-GlobeNewswire
-
Science News unveils its list of 10 scientists making an impact on our world
21/10/2026 -
Atalan to Present New Research on Measuring AI’s Real-World Impact and Predicting Nurse Turnover
21/10/2026 -
Healthcare’s Financial Leaders Pledge Unprecedented Collaboration to Address America’s Healthcare Affordability Crisis
21/10/2026 -
Organic & Natural Health Association Shares 5 Ways Americans Can Protect Their Health as Insurance Costs Rise
21/10/2026 -
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
21/10/2026 -
What joint replacement involves, from the surgeon's credentials to the recovery plan
21/10/2026 -
Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)
21/10/2026 -
Satellos to Participate in Upcoming Investor Conferences
21/10/2026 -
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)
21/10/2026 -
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
21/10/2026 -
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
21/10/2026 -
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
21/10/2026 -
P-Protect Introduces P-Protect Patch - A New Patch-Based Option for Men’s Prostate Wellness
21/10/2026 -
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
21/10/2026 -
TaiMed Biologics Reports IDWeek 2026 Data Highlighting TMB-365 and Its Potential Across Long-Acting HIV Combinations
21/10/2026 -
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
21/10/2026 -
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
21/10/2026 -
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
21/10/2026 -
10X Health Launches Metabolism Genetic Test
21/10/2026
Pages